Capital CS Group, LLC
- SEC CIK
- 0001830008
- Latest filing
- Aug 12, 2026
TGTX holding history
TG Therapeutics, Inc. in every 13F filed by Capital CS Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TGTX overviewAll 13F holders of TGTXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −17,525−100.0% | Sold out | Holders |
| Q3 2024 | 17,525 | $409.9K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2024 | 17,525 | $311.8K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2024 | 17,525 | $266.6K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2023 | 17,525 | $299.3K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 17,525 | $146.5K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 17,525 | $435.3K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2023 | 17,525 | $263.6K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 17,525 | $207.3K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2022 | 17,525 | $104.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 17,525 | $74.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 17,525 | $167.0K | 0.1% | −4,700−21.1% | Reduced | Holders |
| Q4 2021 | 22,225 | $423.0K | 0.3% | +4,700+26.8% | Added | Holders |
| Q3 2021 | 17,525 | $591.0K | 0.6% | +17,525 | New | Holders |